Clinical management of spasticity

Thompson, A. J.; Jarrett, L.; Lockley, L.; Marsden, J.; Stevenson, V. L.
April 2005
Journal of Neurology, Neurosurgery & Psychiatry;Apr2005, Vol. 76 Issue 4, p459
Academic Journal
The article discusses clinical management of spasticity. Spasticity is a common symptom seen in many neurological conditions, notably head injury, spinal cord injury, stroke, cerebral palsy and multiple sclerosis. Drug treatment can be used for generalized spasticity or targeted to focal problems, and can include agents such as botulinum toxin or intrathecal baclofen and phenol. Botulinum toxin is the most widely used treatment for focal spasticity. Unfortunately all drug treatments for spasticity can have side effects, the commonest of which are drowsiness and weakness.


Related Articles

  • Botulinum toxin B.  // Reactions Weekly;1/13/2007, Issue 1134, p9 

    The article presents information on the case of a female patient who developed dysphagia after injections with botulinum toxin B for leg spasticity, lower back and buttock pain. The patient was hospitalized and underwent laryngoscopy. She received liquid diet and her dysphagia stabilized....

  • Neurosurgical Treatment of Spasticity and Other Pediatric Movement Disorders. Albright, A. Leland // Journal of Child Neurology;Sep2003 Supplement, Vol. 18, pS67 

    For children whose spasticity and movement disorders are inadequately treated by oral medications and botulinum toxins, neurosurgical procedures are now available to effectively treat spasticity, tremor, and many cases of dystonia. Spastic diplegia can be treated with selective lumbar...

  • Deadly poison may be helpful in treating cramps.  // Nutrition Health Review: The Consumer's Medical Journal;Spring91, Issue 58, p11 

    Reports on the usefulness of the botulinum toxin for treating spastic muscle conditions and other involuntary muscular problems. Injections of the toxin as an alternative to surgery; Function of the toxin; Preparation of the toxin for human use.

  • Oromandibular dystonia in Yemeni patients with khat chewing: a response to botulinum toxin treatment. Shehata, Hatem S.; El-Tamawy, Mohamed S.; Mohieldin, Nevin; Edrees, Mohammed; Bohlega, Saeed // Neurology International;2014, Vol. 6 Issue 2, p15 

    Khat-(Catha edulis)related oromandibular dystonia is a difficult-to-treat subset of movement disorders that involve masticatory muscles with diverse and incapacitating manifestations. The aim of this study was to evaluate the efficacy of Botulinum toxin-type A therapy in khat chewer Yemeni...

  • Botulinum toxin.  // Reactions Weekly;9/6/2008, Issue 1218, p9 

    The article describes the case of a patient with spinal cord injury who developed strabismus in his right eye after receiving botulinum toxin for spasticity in his lower extremity. According to the author, there are permanent adverse events associated with botulinum toxin. The author adds that...

  • Fluoxetine.  // Reactions Weekly;6/27/2009, Issue 1258, p16 

    The article describes a case of ear moving syndrome in a 23-year-old male patient receiving fluoxetine for tension-type headache. It references a study by K. Hatice et al, presented at the 13th International Congress of Parkinson's Disease and Movement Disorders held on June 7, 2009. Findings of...

  • Botulinum Toxin A (Dysport®): In Dystonias and Focal Spasticity. Keam, Susan J.; Muir, Victoria J.; Deeks, Emma D. // Drugs;2011, Vol. 71 Issue 8, p1043 

    Dysport®, a formulation of botulinum toxin A, blocks acetylcholine release at neuromuscular junctions causing denervation and temporary muscle paralysis. It is used to treat several medical conditions, including dystonias and focal spasticity. Subcutaneous Dysport® was effective in...

  • Efficiency of Repeated Botulinum Toxin Type-A Injections in Post-Stroke Distal Limb Spasticity. ÇOBAN, Arzu; MATUR, Zeliha; HANAGASİ, Hasmet A.; Istanbul, Yeşim PARMAN // Journal of Neurological Sciences;2014, Vol. 31 Issue 1, p21 

    Objective: The purpose of this study was to assess cumulative effect of repeated Botulinum toxin type-A (BT-A) injections in stroke patients with distal upper and lower limb spasticity. Methods: The patients were classified in 2 groups according to their upper and lower limb spasticity. The...

  • Injectable Neuromuscular Blockade in the Treatment of Spasticity and Movement Disorders. Tilton, Ann H. // Journal of Child Neurology;Sep2003 Supplement, Vol. 18, pS50 

    Neuromuscular blockade via injection of alcohol, phenol, or botulinum toxin reduces the tone of overactive muscles in order to restore the appropriate balance between agonists and antagonists. Such a restoration allows improved stretch and increased resting length and can reduce the likelihood...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics